Unlocking Potential in the Pharmaceutical Manufacturing Market
The synthesis of complex active pharmaceutical ingredients (APIs) has become a focal point for investment as the industry moves toward specialized medicine. The current trend suggests a significant move away from chemical synthesis toward large-molecule biologics, which require sophisticated bioreactors and stringent cold-chain logistics. This shift is not merely a change in product type but a...
0 Commentaires 0 Parts 78 Vue 0 Aperçu